Paytm sells PayPay stake to SoftBank for $279.2 million

Date:

Share post:


Paytm has agreed to sell its stake in Japanese payments firm PayPay to SoftBank for $279.2 million, as the Indian firm sheds non-core assets following a bruising regulatory clampdown earlier this year.

The sale of Paytm’s stake in PayPay, which it received through acquisition rights six years ago, follows months of restructuring at the Indian firm that saw the company sell its entertainment ticketing unit to Zomato for $246 million in August.

PayPay, controlled by SoftBank and Yahoo Japan parent Z Holdings, is a leading payments app in Japan.

The stake sale will boost Paytm’s cash reserves to $1.46 billion as it attempts to recover market share in India’s fiercely competitive payments market. The company’s banking affiliate was severely restricted by regulators in January, leading to an exodus of customers to rival services.

Shares in Paytm have nearly tripled since June after India’s payments regulator allowed it to resume adding customers to its flagship UPI service. The company reported its first quarterly profit in September, though this was largely due to proceeds from asset sales rather than operational improvements.

“We are grateful to Masayoshi-san and the PayPay team for giving us the opportunity to together create a mobile payment revolution in Japan,” Paytm said in a statement. “We remain fully committed and will continue to support PayPay’s product and technology innovations in future. We are working on introducing new AI-powered features to accelerate PayPay’s vision in Japan.”

Saturday’s deal marks the end of Paytm’s relationship with SoftBank, which divested its remaining shares in June after being an early backer through its Vision Fund.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Apple board opposes proposal to abolish DEI programs

Apple’s board of directors has come out in opposition to a proposal seeking to end the company’s...

Researchers open source Sky-T1, a ‘reasoning’ AI model that can be trained for less than $450

So-called reasoning AI models are becoming easier — and cheaper — to develop. On Friday, NovaSky, a...

What’s behind ballooning video game budgets?

Why does it cost some companies hundreds of millions of dollars to develop a popular video game? A...

Everything you missed at CES 2025

Welcome back to Week in Review. I missed you! This week, we’re diving into all the gadgets...

I got soaked driving the Arc Sport electric boat

I did not go to CES 2025 with the goal of getting drenched by Lake Mead’s chilly...

We talked to the guy who was stuck in a Waymo robotaxi on a dizzying loop

A month ago, a video circulated around social media of a Waymo robotaxi stuck in a roundabout...

The US has a new cybersecurity safety label for smart devices

The White House this week announced a new label for internet-connected devices, the U.S. Cyber Trust Mark,...

The LiberLive C1 stringless instrument isn’t a guitar, and that’s fine

I’m old enough to remember musicians getting angry over Guitar Hero. But they always seemed to be...